As pharmaceutical companies invest more in research and development (R&D), demand for skilled professionals to run clinical trials is rising. However, the supply of these professionals is limited, and an aging workforce may further reduce their number in the coming years. he pandemic and the “Great Resignation” intensified the problem and continue to affect the availability of experienced professionals, even as companies accelerate trials paused during COVID-19. Some executives are concerned that a significant share of the R&D workforce could retire soon.
Resource management—ensuring the right personnel are in place for clinical trials—remains critical for pharmaceutical companies developing the next generation of life sciences breakthroughs.
As the white paper discusses, analytics play a key role in efficient human resource management in \R&D. The authors also highlight the value of a resource management center of excellence to standardize forecasting and capacity management, remove bias and support capability development.
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
